Optimization of Recombinant Antibody Production in CHO Cells
The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed enhance antibody titer, comprising process parameter optimization, cell line development, and adoption of perfusion systems. Fine-tuning growth parame